Copyright © 2000 by the European Society of Cardiology.
Left ventricular outflow tract gradient decrease with non-surgical myocardial reduction improves exercise capacity in patients with hypertrophic obstructive cardiomyopathy
y
of1
mierczyk-DroszczeckaNational Institute of Cardiology, Warsaw, Poland
Received August 23, 1999; accepted August 25, 1999
Abstract
Objectives This study was undertaken to evaluate mid-term clinical results of non-surgical myocardial reduction in patients with hypertrophic obstructive cardiomyopathy.
Methods Twenty-five patients with left ventricular outflow tract obstruction (mean gradient of 84·54±31·38mmHg) and symptoms of dyspnoea, angina and/or syncope were treated with non-surgical myocardial reduction. The patients were followed-up for a mean period of 10·44±1·8 months. In all patients clinical examination with echocardiography was repeated after every 3 months of follow-up, and a symptom-limited treadmill test was repeated at the 6 month follow-up. Eighteen patients underwent simultaneous respiratory gas analysis.
Results Clinical follow-up examinations were achieved in all 25 patients. Persistent left ventricular outflow tract gradient reduction was seen in 23 patients. Seventeen patients had a reduction of left ventricular outflow tract gradient >50% of baseline value. Twenty patients showed a clinical improvement from 2·8±0·5 up to 1·2±0·5 NYHA class (P<0·001). The clinical improvement was matched by an improvement in objective measures of exercise capacity in patients with significant left ventricular outflow tract gradient reduction. Exercise time increased from 571·9±192·2 to 703·5±175·4s, P<0·001, and peak VO2increased from 14·6±5·2 to 20·5±8·6ml.kg–1min–1,P <0·05.
Conclusion Significant left ventricular outflow tract gradient reduction with exercise capacity improvement was achieved in the majority of patients treated with non-surgical myocardial reduction. We recommend this method as an alternative to surgery for symptomatic patients with hypertrophic obstructive cardiomyopathy.
Key Words: Hypertrophic obstructive cardiomyopathy, catheter therapy, exercise capacity
f1 Correspondence: W. Ru
y<<o, MD, FESC, Professor of Cardiology, Department of General Cardiology and Catheterization Laboratory, National Institute of Cardiology, Alpejska 42 Poland, 04-628 Warsaw, Poland.
References
- Watkins H. Multiple disease genes cause hypertrophic cardiomyopathy. Br Heart J. 1994;72:54–59
- Henry WL, Clark CE, Griffith JM, Epstein SE. Mechanism of left ventricular outflow obstruction in patients with obstructive asymmetric septal hypertrophy (idiopatic hypertrophic subaortic stenosis). Am J Cardiol. 1975;35:337–345[CrossRef][ISI][Medline]
- Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE. Hypertrophic cardiomyopathy: Interrelation of clinical manifestations, pathophysiology and therapy. N Engl J Med. 1987;316:780–789[ISI][Medline]
- Grigg LE, Wigle ED, Williams WG, Daniel LB, Rakowski H. Transesophageal Doppler echocardiography in obstructive cardiomyopathy: clarification of pathophysiology and importance of intraoperative decision making. J Am Coll Cardiol. 1992;20:42–52[Abstract]
- Chikamori T, Counihan P, Doi J. Mechanisms of exercise limitation in hypertrophic cardiomyopathy. J Am Coll Cardiol. 1992;19:507–512[Abstract]
- Sigwart U. Non-surgical reduction for hypertrophic obstructive cardiomyopathy. Lancet. 1995;346:211–214[CrossRef][ISI][Medline]
- Knight Ch, Kurbaan A, Seggewiss H. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy. Outcome in the first series of patients. Circulation. 1997;95:2075–2081
[Abstract/Free Full Text] - Gietzen F, Kuhn H, Leuner Ch, Gerenkamp T, Hegselmann J, Raute-Kreinsen U. Acute and long-term results of transcoronary ablation of septum hypertrophy in hypertrophic obstructive cardiomyopathy (Abstr). Eur Heart J. 1997;18:468
- Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt H, Strick S. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol. 1998;31:252–258
[Abstract/Free Full Text] - Nagueh S, Lakkis N, Zuo-Ziang HE. Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 1998;32:225–229
[Abstract/Free Full Text] - Circulation. 1996;93:841–842
[Free Full Text] - Schulte HD, Bircks W, Losse B, Godehardt E, Schwartzkopff B. Prognosis of patients with hypertrophic obstructive cardiomyopathy after transaortic myectomy. Late results up to twenty-five years. J Thorac Cardiovasc Surg. 1993;106:709–711[Abstract]
- Schönbeck MH, Brun
er-La Rocca HP, Vogt PR. Long-term follow-up in hypertrophic obstractive cardiomyopathy after septal myectomy. Ann Thorac Surg. 1998;65:1207–1214[Abstract/Free Full Text] - Theodoro D, Danielson G, Feldt R, Anderson B. Hypertrophic obstructive cardiomyopathy in pediatric patients: results of surgical treatment. J Thorac Cardiovasc Surg. 1996;112:1589–1599
[Abstract/Free Full Text] - Kappenberger L, Linde C, Daubert C. Pacing in hypertrophic obstructive cardiomyopathy. A randomised crossover study. Eur Heart J. 1997;18:1249–1256
[Abstract/Free Full Text] - Nishimura R, Trusty J, Hayes D. Dual-chamber pacing for hypertrophic cardiomyopathy: A randomised, double-blind, crossover trial. J Am Coll Cardiol. 1997;29:435–441[Abstract]
- Waller BF, Maron BJ, Epstein SE, Roberts WC. Transmural myocardial infarction in hypertrophic cardiomyopathy: A cause of conversion from left ventricular asymmetry and from normal-size to dilated left ventricular cavity. Chest. 1981;79:461–465
[Abstract/Free Full Text] - Come PC, Riley MF. Hypertrophic cardiomyopathy. Disapperance of ausculatory, carotid pulse, and echocardiographic manifestations of obstruction following myocardial infarction. Chest. 1982;82:451–454
[Abstract/Free Full Text] - Sigwart U, Grbic M, Essinger A, Rivier JL. L'effet aigu d'une occlusion coronarienne par ballonet de la dilatation transluminale (Abstr). Schweiz Med Wochenschr. 1982;45:1631
- Gietzen F, Leuner Ch, Gerenkamp T, Kuhn H. Relief of obstruction in hypertrophic cardiomyopathy by transient occlusion of the first septal branch of the left coronary artery (Abstr). Eur Heart J. 1994;15:125
[Abstract/Free Full Text] - Ka
mierczak J, Kornacewicz-Jach Z, Kis<y H, Gil R, Wojtarowicz A. Electrocardiographic changes after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Heart. 1998;80:257–262[Abstract/Free Full Text] - Sigwart U, Gibson D, Henein M, Anderson R. Clinical significance of obstruction of the first major septal branch. Circulation. 1998;98:377–378
[Free Full Text]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S C Agarwal, I F Purcell, and S S Furniss Apical myocardial injury caused by collateralisation of a septal artery during ethanol septal ablation Heart, January 1, 2005; 91(1): e2 - e2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, F. J. Ten Cate, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1687 - 1713. [Full Text] [PDF]
|
|
|
|
 |
|
 Writing Committee Members, B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines Eur. Heart J., November 1, 2003; 24(21): 1965 - 1991. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Braunwald, C. E. Seidman, and U. Sigwart Contemporary Evaluation and Management of Hypertrophic Cardiomyopathy Circulation, September 10, 2002; 106(11): 1312 - 1316. [Full Text] [PDF]
|
|
|
|
|
|
E. D. Wigle, L. Schwartz, A. Woo, and H. Rakowski To ablate or operate? that is the question! J. Am. Coll. Cardiol., November 15, 2001; 38(6): 1707 - 1710. [Full Text] [PDF]
|
|
|
|
|
|
R. Roberts and U. Sigwart New Concepts in Hypertrophic Cardiomyopathies, Part II Circulation, October 30, 2001; 104(18): 2249 - 2252. [Full Text] [PDF]
|
|
|
|
 |
|
 U. Sigwart Non-surgical myocardial reduction for patients with hypertrophic obstructive cardiomyopathy Eur. Heart J. Suppl., October 1, 2001; 3(suppl_L): L38 - L42. [Abstract] [PDF]
|
|
|
|
|
|
P.P. Dimitrow, D. Dudek, and J.S. Dubeil The risk of alcohol leakage into the left anterior descending coronary artery during non-surgical myocardial reduction in patients with obstructive hypertrophic cardiomyopathy. Eur. Heart J., March 1, 2001; 22(5): 437 - 437. [PDF]
|
|
|
|
|
|
H. Seggewiss Percutaneous transluminal septal myocardial ablation: A new treatment for hypertrophic obstructive cardiomyopathy Eur. Heart J., May 1, 2000; 21(9): 704 - 707. [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||